{
    "nctId": "NCT03573661",
    "briefTitle": "A Pilot Multi-Institutional Study to Evaluate the Accuracy of a Breast Cancer Locator in Patients With Palpable Cancers",
    "officialTitle": "A Pilot Multi-Institutional Study to Evaluate the Accuracy of a Breast Cancer Locator in Patients With Palpable Cancers",
    "overallStatus": "COMPLETED",
    "conditions": "Palpable Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "NA",
    "primaryPurpose": "DEVICE_FEASIBILITY",
    "enrollmentCount": 18,
    "primaryOutcomeMeasure": "The proportion of patients who had the localization wire placed within the cancer on the specimen mammogram",
    "eligibilityCriteria": "Inclusion Criteria:\n\n1. Age \\> 18 years.\n2. Histologic diagnosis of palpable invasive breast cancer or ductal carcinoma in situ.\n3. Patient desire to undergo breast surgery (lumpectomy or non-skin sparing mastectomy).\n4. Ability to voluntarily provide informed consent to participate prior to any study-related assessments/procedures being conducted.\n5. The cancer enhances on prone breast MRI imaging\n6. The cancer is visible on mammography.\n\nExclusion Criteria:\n\n1. Absolute contraindication to MRI, including presence of implanted electrical device (pacemaker or neurostimulator), aneurysm clip, or metallic foreign body in or near eyes.\n2. Severe claustrophobia.\n3. Contraindication to use of gadolinium-based intravenous contrast, including life- threatening allergy or compromised renal function (creatinine \\> 2.0).\n4. History of median sternotomy.\n5. Pregnancy. Patient attestation that they are not pregnant will be acceptable.\n6. Patients receiving neoadjuvant chemotherapy.",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}